Cargando…
Explicating the Pivotal Pathogenic, Diagnostic, and Therapeutic Biomarker Potentials of Myeloid-Derived Suppressor Cells in Glioblastoma
Glioblastoma (GBM) is a malignant and aggressive central nervous tumor that originates from astrocytes. These pathogenic astrocytes divide rapidly and are sustained by enormous network of blood vessels via which they receive requisite nutrients. It well proven that GBM microenvironment is extremely...
Autor principal: | Richard, Seidu A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657691/ https://www.ncbi.nlm.nih.gov/pubmed/33204365 http://dx.doi.org/10.1155/2020/8844313 |
Ejemplares similares
-
Elucidating the pathogenic and biomarker potentials of FOXG1 in glioblastoma
por: Richard, Seidu A., et al.
Publicado: (2020) -
Metabolic and functional reprogramming of myeloid-derived suppressor cells and their therapeutic control in glioblastoma
por: Won, Woong-Jai, et al.
Publicado: (2019) -
Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19
por: Rowlands, Marianna, et al.
Publicado: (2021) -
Myeloid-Derived Suppressor Cells: A New and Pivotal Player in Colorectal Cancer Progression
por: Yin, Kai, et al.
Publicado: (2020) -
Exploring the Pivotal Neurophysiologic and Therapeutic Potentials of Vitamin C in Glioma
por: Richard, Seidu A., et al.
Publicado: (2021)